Radiological evaluation of covered self-expandable metallic stents used for palliation in patients with malignant esophageal strictures

Neyaz, Zafar; Srivastava, Deep Narayan; Thulkar, Sanjay; Bandhu, Suman; Gamanagatti, S; Julka, P.K.; Chattopadhyaya, T. K.

doi:10.1080/02841850601129007

Cited by 9 publications

(7 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…SEMSs have been successfully used since the early 1990s for palliation of primary esophageal cancer. 13,[19][20][21][22][23] However, the efficacy of SEMS therapy in patients with recurrent cancer after esophagectomy is not well established. The current cohort study, which is the largest published to date, shows a clear benefit of SEMS therapy in patients with recurrent tumor growth after esophagectomy.…”

Section: Discussionmentioning

confidence: 99%

Esophageal stents for the palliation of malignant dysphagia and fistula recurrence after esophagectomy

Heel

Haringsma

Spaander

et al. 2010

Gastrointestinal Endoscopy

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Esophageal stents for the palliation of malignant dysphagia and fistula recurrence after esophagectomy

Heel

Haringsma

Spaander

et al. 2010

Gastrointestinal Endoscopy

View full text Add to dashboard Cite

“…In the present study, a high success rate of stent placement was evident, with adequate relief of dysphagia in most patients. The technical success and symptom improvement rates were comparable to patients without previous surgery 10,11 . Food bolus obstruction after stenting accounted for most of the re‐intervention episodes.…”

Section: Discussionmentioning

confidence: 58%

The use of self-expanding metallic stents (SEMS) is effective in symptom palliation from recurrent tumor after esophagogastrectomy for cancer

Tong

Law

Wong

2010

Diseases of the Esophagus

View full text Add to dashboard Cite

The efficacy of using self-expanding metallic stent (SEMS) for palliation of symptoms because of tumor recurrence after prior esophagogastrectomy has not been properly assessed despite the well recognized use of SEMS in patients without prior surgery. The aim of this study is to evaluate the efficacy and safety of using SEMS in patients who had prior esophagogastrectomy. The study group included 35 patients with carcinoma of esophagus or cardia documented to have loco-regional recurrence after esophagogastrectomy and in whom SEMS were placed for palliation. The median age was 67 (ranged 41-85). The indications for stenting were dysphagia caused by recurrence at the esophageal anastomosis (n= 4) and in the esophageal remnant (n= 5), or extrinsic compression from mediastinal nodal disease (n= 7); gastric outlet obstruction produced by extrinsic tumor compression (n= 13); and tracheo-esophageal fistulae (n= 6). Forty-three stenting procedures were performed, and the technical success rate was 97.6%. The dysphagia score improved from 4.66 to 2.54 (P < 0.001). All patients with tracheo-esophageal fistula had their symptoms successfully palliated. The immediate complication rate was 14% (n= 5); two patients had stent malpositioning, two had inadequate opening of their stents, and one had a failed stenting procedure. On follow-up, 15 (42.8%) patients required a total of 22 re-intervention procedures for various reasons: endoscopic dilatation (five dilatations in three patients), removal of foreign bodies (nine procedures in four patients), and insertion of a second SEMS related to tumor growth (eight stents in eight patients). There was no procedure-related mortality. The median survival was short at 42 days (range 5-290 days), mostly related to advanced disease stage. SEMS in patients with recurrent tumor after esophagogastrectomy is safe and effective.

show abstract

“…However, migration rate is higher in coated stents. In light of these information, semi-coated metallic stents were preferred for malignant upper gastrointestinal tract stenoses in this study (5)(6)(7).…”

Section: Discussionmentioning

confidence: 95%

“…In upper gastrointestinal tract stenoses, stent procedures are minimally invasive procedures that are easy to perform and lead to rapid improvement in dysphagia symptoms. However, they can lead to complications with high morbidity and mortality rates such as bleeding, perforation, retrosternal pain, aspiration pneumonitis, arrhythmia, stent migration, stent occlusion, and tracheoesophageal fistula (6). Complication rates in stent placement without fluoroscopy are around 5% (4).…”

Section: Discussionmentioning

confidence: 99%

Safety of Esophageal Stent Placement Without Fluoroscopy

Dincer¹,

Çıtlak²,

Gür³

et al. 2018

Kocaeli Med J

View full text Add to dashboard Cite

show abstract

Radiological evaluation of covered self-expandable metallic stents used for palliation in patients with malignant esophageal strictures

Cited by 9 publications

References 23 publications

Esophageal stents for the palliation of malignant dysphagia and fistula recurrence after esophagectomy

Esophageal stents for the palliation of malignant dysphagia and fistula recurrence after esophagectomy

The use of self-expanding metallic stents (SEMS) is effective in symptom palliation from recurrent tumor after esophagogastrectomy for cancer

Safety of Esophageal Stent Placement Without Fluoroscopy

Contact Info

Product

Resources

About